JAK inhibitor
Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo
... targeting JAK/STAT3 may have a broad spectrum of antitumor ...JAK1/2 inhibitor, exhibits anti-tumor potency in multiple adult ...of JAK/STAT3 signal transduction pathway we assessed the activity of ...
13
Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome
... the JAK inhibitor baricitinib for the past year and we observed a significant amelioration of his inflammatory episodes, skin and joint manifestations, and improvements in physical activities and ...
7
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms
... addition, JAK/MEK inhibition reversed fibrosis to an extent not seen with JAK inhibitor monotherapy (Figure ...MEK1/2 inhibitor, was also effective in suppression of ERK phosphorylation and ...
17
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
... particular JAK/STAT, could reverse AA in mice ...pan-JAK inhibitor, tofacitinib citrate (6); 3 patients with the JAK1/2 inhibitor, ruxolitinib (5); and 1 patient with JAK1/2 inhibitor, ...
11
Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
... the JAK family are known: JAK1, JAK2, JAK3, and ...oral JAK inhibitor that is now available and effective in RA treatment, as shown in multiple Phase II and Phase III clinical ...
9
European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib
... first JAK inhibitor approved by the US Food and Drug Administration (FDA) and European Medi- cines Agency (EMA) in the RA therapy, thus providing a useful alternative treatment ...
15
Heart regeneration for clinical application update 2016: from induced pluripotent stem cells to direct cardiac reprogramming
... A83-01: Inhibitor of TGF- β type I receptor, ALK5 kinase; ADHF: Adult human dermal fibroblasts; AHCF: Adult human cardiac fibroblasts; ALK: Activin receptor- like kinase; AS8351: 2-Hydroxy-1-naphthylaldehyde ...
13
Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials
... other JAK inhibitors in devel- ...JAK1/JAK2 inhibitor, in com- bination with nonbiologic DMARDs, increases in SCr of ...selective inhibitor, VX-509, increases in SCr across the dose range were re- ...
12
Areca nut components stimulate ADAM17, IL-1 , PGE2 and 8-isoprostane production in oral keratinocyte: role of reactive oxygen species, EGF and JAK signaling
... (MEK inhibitor) but not by ` -naphthoflavone (cytochrome p450-1A1 ...(Src inhibitor), U0126, `-naphthoflavone and aspirin. AG490 (JAK inhibitor) prevented ANE-stimulated ADAM17, IL-1`, PGE 2 ...
16
JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope-Mutated HIV-1
... of JAK inhibitors to counteract IL-2 because IL-2 activates JAK3 and because tofacitinib is its specific ...of JAK inhibitor-treated samples over 21 days, as monitored by p24 ...without JAK ...
15
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
... Ruxolitinib has undergone 2 separate randomized con- trolled trials, referred to as the COntrolled MyeloFibrosis study with ORal JAK inhibitor Treatment (COMFORT) I & II (Table 2) [66,67]. Patients were ...
10
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open label long term extension studies
... A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib CP-690,550 versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis an[r] ...
13
Treatment and management of myelofibrosis in the era of JAK inhibitors
... A challenge in the introduction of novel therapies is determining both the current prevalence of disease and the true societal cost – this is poorly understood for MF, and efforts should focus here. If we could better ...
10
Tofacitinib facilitates the expansion of myeloid derived suppressor cells and ameliorates interstitial lung disease in SKG mice
... Background: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a sometimes life-threatening complication in RA patients. SKG mice develop not only arthritis but also an ILD resembling RA-ILD. We ...
9
CP690,550 inhibits oncostatin M induced JAK/STAT signaling pathway in rheumatoid synoviocytes
... JAK inhibitor CP690,550 was obtained from Axon Bio- chemicals (Postbus, ...against JAK-1 (Tyr1022/1023), JAK-2 (Tyr1007/1008), STAT-1 (Tyr701), STAT-3 (Tyr705), STAT-5 (Tyr694), ERK-1/2 ...
10
MECHANISMS OF THE DOWNREGULATION OF PROLACTIN RECEPTOR AND THEIR ROLE IN CELL PROLIFERATION
... either Jak inhibitor AG490 or Src inhibitor PP1 and we measured the internalization of PRLr in the absence or presence of ligand using the fluorescence-based internalization ...Src inhibitor ...
173
Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis
... Perhaps the most evident effect of pSTAT1 blockade by TOFA at the rabbit synovial tissue was the potent downregulation of MMP-1, -3 and -13, considering their prominent role in the invasive transformation of the ...
10
The central role of SOCS 3 in integrating the neuro immunoendocrine interface
... potent inhibitor of LIF-induced JAK-STAT signaling, SOCS-3 negatively regulates its own cytokine-induced expression at the mRNA level by a short intracellular inhibitory feedback loop (Figures 1 and ...
7
Inhibition of Interferon-Stimulated JAK-STAT Signaling by a Tick-Borne Flavivirus and Identification of NS5 as an Interferon Antagonist
... IFN-mediated JAK-STAT (Janus kinase-signal transducer and activator of transcription) pathway of signal ...of JAK-STAT signaling and NS5-IFN receptor interactions were demonstrated in LGTV-infected human ...
12
JAK STAT signaling in asthma
... The cytokines IL-12 and IL-4 direct the differentia- tion of Th1 and Th2 cells, respectively, from naive T helper cells (6, 7). Genetic studies have confirmed the physiologic importance of these cytokines in vivo. Mice ...
6